The Advancement of Stem Cell Technology
Welcome to the Manhattan Regenerative Medicine Medical Group, an affiliate of the California Stem Cell Treatment Center / Cell Surgical Network of Beverly Hills and Rancho Mirage, California, USA.
Our affiliated Centers utilize cutting edge advanced techniques and innovative technology to improve the health and well being of our patients.
At the Manhattan Regenerative Medicine Medical Group, we engage in the investigational use of Adult Adipose-derived Stem Cells (ADSCs) for clinical research and deployment through which patients who are suffering from diseases that may have limited treatment options have an opportunity to respond to stem cell based regenerative medicine and further advance the state of medicine, knowledge, and options for all patients.
Our expertise involves a deep commitment and long-term understanding, knowledge and experience in clinical research and the advancement of regenerative medicine. Our staff and Physicians at the Manhattan Regenerative Medicine Medical Group have been trained by the Founders and world renown specialists of the California Stem Cell Treatment Center, who have been nationally recognized for working with autologous (your own) Adult Autologous Adipose-adipose derived Stem Cells (ADSCs) providing investigational therapy to patients with various inflammatory and/or degenerative conditions.
Our Centers utilize a fat transfer technology to isolate and implant the patients ownAdult Autologous Adipose-derived Stem Cells (ADSCs) from a small quantity of fat harvested by mini-liposuction on the same day. Using technology developed in South Korea, our Centers have developed an in-office procedure to isolate a cellular medium called Stromal Vascular Fraction (SVF) which is rich in progenitor and Stem Cells. Our Founders have also worked in conjunction with a number of international organizations and physicians of great expertise to help develop our protocols for procedures. Whereas the California Stem Cell Treatment Center was developed in 2010, in 2012, the Cell Surgical Network (CSN) was formed to provide the same high level quality controlled investigational therapy both nationally and internationally.
Our Protocols are approved by an IRB (Institutional Review Board), and accordingly we are able to safely provide adipose (fat)-derived stem cell procedures on an investigational basis to our patients.The approving IRB is registered with the U.S. Department of Health, Office of Human Research Protection (OHRP). Modeled after the California Stem Cell Treatment Center, weve formed a multidisciplinary team to evaluate patients with a variety of conditions which are known to often be responsive to Stem Cell therapy.
All affiliate members of the California Stem Cell Treatment Center / Cell Surgical Network, including our Manhattan Regenerative Medicine Medical Group, contribute to the California Centers IRB approved investigational data. In this manner, we are continuously updating, researching, and learning more on how to help patients and advance the state of the art of regenerative medicine.
All patients who are interested in our investigational protocols will be evaluated by our physicians specially trained in our adipose-derived stem cell procedures and given an honest opinion as to the potential benefits and risks of stem cell therapy for their presenting condition.
The Manhattan Regenerative Medicine Medical Group is proud to be part of the only Institutional Review Board (IRB)-based stem cell procedure network in the United States that utilizes fat-transfer surgical technology. We have an array of ongoing IRB-approved protocols, and we provide care for patients with a wide variety of disorders that may benefit from adult stem cell-based regenerative therapy. At the Manhattan Regenerative Medicine Medical Group we exploit anti-inflammatory, immuno-modulatory and regenerative properties of AdultAutologous Adipose-derived Stem Cells (ADSCs) to mitigate inflammatory and degenerative diseases.
At the Manhattan Regenerative Medicine Medical Group we provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. Our Center utilizes a fat-transfer surgical technology to isolate and implant the patients ownAutologous Adipose-derived Stem Cells from a small quantity of fat harvested by a mini-liposuction on the same day. Please review our Medical Conditions for more information.
The California Stem Cell Treatment Center was founded in 2010 for the investigational use of stem cell procedures for degenerative conditions. The California Stem Cell Treatment Center employs a clinical research coordinator to protect our valuable data, as our vision is to perfect our methods and ultimately teach them to others.